Concepedia

Victor Ruiz‐Rodado

VR

Statistics

Publications

20

Citations

878

H-Index

16

Active since

2014

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

De Montfort University

Heidelberg University

Victor Ruiz‐Rodado is an author at National Cancer Institute specializing in life sciences, oncology, and metabolic reprogramming in cancer.

ORCID

Publications per year

2014–2021

20

Publications

20

Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism

Di Yu, Yang Liu, Yiqiang Zhou et al. · Proceedings of the National Academy of Sciences · 2020 · 146 citations · Full text

, , +17

Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

Choh Yeung, Anna E. Gibson, Sameer H. Issaq et al. · Cancer Research · 2019 · 130 citations · Full text

, , +14

Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma

Ling Ren, Victor Ruiz‐Rodado, Tyrone Dowdy et al. · Cancer & Metabolism · 2020 · 103 citations · Full text

, , +16

IDH1 mutations induce organelle defects via dysregulated phospholipids

Adrian Lita, Artem Pliss, Andrey N. Kuzmin et al. · Nature Communications · 2021 · 78 citations · Full text

, , +12

Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas

Victor Ruiz‐Rodado, Tathiane M. Malta, Tomohiro Seki et al. · Neuro-Oncology · 2019 · 65 citations · Full text

, , +15

1–5 of 20